Outcome of Board Meeting

BANKA BIOLOO LIMITED Registered Office: A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004 Corporate Office: 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016 +91 8688825013 • info@bankabio.com • www.bankabio.com • CIN: L90001TG2012PLC082811 An ISO 9001-2015-14001-2015-45001-2018 Company BBL/ SECT/21/2026-27 Date: 13 August 2026 The Listing Department National Stock Exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: BANKA Dear Sir/Madam, Sub: Outcome of Board Meeting dated 13 August 2026 and Integrated Filings (Financial) Ref: Regulation 30 & 33 read with sub-para 4 of Para “A” of Part “A” of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). This is to inform you that the Board of Directors at its Meeting held today, i.e., 13 August 2026, considered and approved the following: 1) Unaudited standalone and consolidated financial results of the Company for the quarter and three months ended 30 June 2026, based on recommendation of Audit Committee. 2) Limited Review Reports (standalone and consolidated) thereon, for the quarter and three months ended 30 June 2026, based on recommendation of Audit Committee. A copy of the aforementioned Financial Results along with the Auditors’ Reports thereon pursuant to Regulation 33 of SEBI Listing Regulations are enclosed herewith. We are also arranging to upload the aforesaid Financial Results on the Company’s website at https://www.bankabio.com/investors and shall publish the Financial Results in the newspapers, in the format prescribed under Regulation 47 of the SEBI Listing Regulations. 3) Based on recommendation of Nomination and Remuneration Committee and subject to approval of members of the Company, in the ensuing Annual General Meeting, re- appointment of Mrs. Namita Sanjay Banka (DIN: 05017358) as Managing Director of the Company, who retires by rotation, and being eligible offers herself for re-appointment. (Details provided in Annexure I) 4) Approved the Board Report, along with its annexures, for the year ended 31 March 2026 along with Management Discussion and Analysis Report, Corporate Governance Report and Secretarial Audit Report. 5) Approved and adopted following amended policies:  Policy on related party transactions  Policy on material subsidiary of the Company These are being uploaded at website of the Company at https://www.bankabio.com/investors. 6) Approved holding of 14th Annual General Meeting of the Company on Thursday, 17 September 2026, through video conferencing/other audio video visual means (VC/OAVM) at along with approving the notice of said Annual General Meeting. 7) Appointment of Mr. M Ramana Reddy, (C P No. 18415), Practicing Company Secretary, as Scrutinizer for the purpose of 14th Annual General Meeting of the Company. 8) Based on the recommendation of the Nomination and Remuneration Committee, approved and granted 16,000 ESOPs under the “Banka BioLoo Limited Employees Stock Option Plan - 2023” (“Plan” or “ESOP 2023” or “Scheme”) The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Circular’), are enclosed in Annexure This intimation shall also be considered as Integrated Filing (Financial) for the quarter and three months ended 30 June 2026 pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with relevant SEBI Circulars, as amended and notified from time to time. We request you to take the aforesaid on record, and to treat the same as compliance with the applicable provisions of the Listing Regulations The meeting commenced at 02:30 PM and concluded at 5:00 PM. We request you to kindly take note of the same in your record. Thank you, For Banka BioLoo Limited Manjula Chunduru Company Secretary & Compliance Officer Encl: As above Annexure I Details as required under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular dated 30th January 2026, as amended from time to time Particulars Mrs. Namita Sanjay Banka Reason for change Re-appointment of Mrs. Namita Sanjay Banka, Managing Director, of viz. appointment, the Company, who retires by rotation. resignation, removal, death or otherwise Date of appointment Date of Re-appointment: & Terms of With effect from ensuing Annual General Meeting appointment Terms of Re-appointment: Reappointment of Mrs. Namita Sanjay Banka, Managing Director of the Company, who retires by rotation, subject to the approval of members in the ensuing Annual General Meeting. Brief Profile Mrs. Namita Sanjay Banka aged 53 years, is a promoter and Managing Director of the Company. She completed her Bachelor of Science (Home Science) from University of Delhi, and completed Post- Graduate Diploma in Jewellery Designing, Manufacturing & Appraising from Indian Diamond Institute, Surat. She has over 15 years of experience in the sanitation and waste management sector. She has been a guiding force behind the growth and business strategy of our Company. Disclosure of  Mr. Sanjay Banka (Executive Chairman): Spouse relationships between directors (in  Mr. Vishal Murarka (Executive Director & Chief Executive case of appointment Officer): Brother of a director) Except as stated above, Mrs. Namita Sanjay Banka is not related to any other Director. Information as Mrs. Namita Sanjay Banka is not debarred from holding office of required pursuant to Director by virtue of any Securities and Exchange Board of India NSE Circular Ref. No. (SEBI) order or any other such statutory authority. SE/CML/2018/24 dated June 20, 2018 Annexure II Details as required under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular dated 30th January 2026, as amended from time to time Particulars Details Brief details of options granted 16,000 (Sixteen Thousand) Options granted to the eligible employees of the Company under the Banka BioLoo Limited Employees Stock Option Plan – 2023 (“Scheme”) Whether the scheme is in terms of SEBI Yes (SBEBASE) Regulations, 2021 (if applicable) Total number of shares covered by these 16,000 (Sixteen Thousand) Options granted shall options be exercisable into 16,000 (Sixteen Thousand) Equity Shares of face value Rs.10/- (Rupee Ten) each. Pricing Formula At face value i.e. Rs.10/- (Rupee Ten) each Options vested Not Applicable Vesting schedule The options would vest in the following manner: i. Upon completion of 12 calendar months from the date of grant; 25% of the Options shall vest; ii. Upon completion of 24 calendar months from the date of grant; 25% of the Options shall vest; iii. Upon completion of 36 calendar months from the date of grant; 25% of the Options shall vest; iv. Upon completion of 48 calendar months from the date of grant; 25% of the Options shall vest; Time within which option may be The Options granted can be exercised by the exercised eligible employee within 2 years from the date of vesting of options. Options exercised Not Applicable Money realized by exercise of options Not Applicable The total number of shares arising as a Not Applicable result of exercise of option Options lapsed Not Applicable Variation of terms of options Not Applicable Brief details of significant terms  The terms of the grant of options, provides for the manner in which options would be dealt with, in case of death, permanent incapacity, resignation, termination, retirement, abandonment, etc.  The equity shares allotted, pursuant to the exercise of the stock options, would not be subject to lock-in.  ESOP Shares arising on the conversion of the Options shall rank pari passu with all the other equity Shares of the Company for the time being in issue, from the date of allotment. Subsequent changes or cancellation [Showing first 8,000 characters — download PDF for full document]